Ralph Benedict, Maria Pia Sormani, Marisa McGinley, Douglas Arnold, Amit Bar-Or, Robert Bermel, Pavan Bhargava, Declan Chard, Guy Gherardi, Roland Henry, Owain Howell, Christine Lebrun-Frenay, Letizia Leocani, Catherine Lubetzki, Agne Kazlauskaite, Thomas Kuenzel, Xavier Montalban, Finn Sellebjerg, Giancarlo Comi, Licinio Craveiro, Helmut Butzkeuven. A multicenter, open label, single-arm, phase 3b study (CONSONANCE) to assess efficacy of ocrelizumab in patients with primary and secondary progressive multiple sclerosis: year 1 interim analysis of cognition outcomes (P1-1.Virtual). Neurology. 2022 May 3; 98(18_supplement).